Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01080313 · ClinicalTrials.gov registry record
Head and Neck Cancer Registry (LORHAN)
A clinical trial, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- 26,000
- Enrollment target
NCT01080313 is a clinical trial that has completed, run by Eli Lilly and Company. The registered enrollment target is 26,000 participants.
The verdict
NCT01080313 has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- 26,000 participants
- Enrollment target
Study Summary
The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient
Interventions
- OTHER Therapy for head and neck cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,000 participants |
| Start Date | 2005-08 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01080313
The ClinicalTrials.gov registry entry for NCT01080313 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Therapy for head and neck cancer is the first listed.
NCT01080313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01080313 about?
NCT01080313 is a clinical study titled "Head and Neck Cancer Registry (LORHAN)". The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient
What is the current status of trial NCT01080313?
This trial is currently completed. The enrollment target is 26,000 participants. The study started on 2005-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01080313?
The interventions under investigation include: Therapy for head and neck cancer (OTHER).
Who is sponsoring clinical trial NCT01080313?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.